MUK Nine b: OPTIMUM, paving the way to effectively treat newly diagnosed high-risk MM
Exportin (XPO1) inhibitors for the treatment of AML
Novel ALL treatment strategies: CAR T-cells
New applications for MRD measurement in myeloma: MRD 'over time'
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?